Adriana Marques Faria

Adriana Marques Faria

Auto-generated profile, based on publicly available information

Adriana Marques Faria

Universidade Federal de Goiás, Brazil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Ciência Animal Brasileira
Verified
Journal Article
Open access
PDF file
HFHugo Henrique Ferreira
Hugo Henrique Ferreira
DTDenise Caroline Toledo
Denise Caroline Toledo
AFAdriana Marques Faria
Adriana Marques Faria
DADiego Pereira D.P. Araújo
Diego Pereira D.P. Araújo
ANAndrigo Barboza de Nardi
Andrigo Barboza de Nardi
Veridiana Maria Brianezi Dignani de MouraVeridiana Maria Brianezi Dignani de Moura
Veridiana Maria Brianezi Dignani de Moura
The aim of this study was to perform the immunostaining of MMP-9 and MMP-2 and its inhibitors, TIMP-1 and TIMP-2, on normal and neoplastic canine mammary tissue in order to evaluate the behavior of these proteins in extracellular matrix (ECM) remodeling in different neoplastic mammary types. Thus, 48 samples of canine mammary tissue were analyzed, 14 of which complex carcinomas, 13 tubulopapillary carcinomas, six single adenomas and 15 normal mammary tissue. There were differences in MMP-9, TIMP-1 and TIMP-2 according to mammary histomorphology, and MMP-9 presented increased immunoexpression in epithelial and stromal cells in tubulopapillary and complex carcinomas. TIMP-1 exhibited reduced immunostaining in the stromal cells of the complex carcinomas and TIMP-2 enhanced immunostaining in the epithelial cells of tubulopapillary carcinomas. There was a positive correlation between MMP-9 and TIMP-1 in epithelial and stromal cells regarding immunostaining intensity and number of labeled cells in the normal breast. There was a positive correlation between MMP-9 and TIMP-2 in the epithelial cells of tubulopapillary carcinomas. It is concluded that balanced activity between MMP-9, MMP-2, TIMP-1 and TIMP-2 maintains normal canine mammary tissue homeostasis while increased immunoexpression of MMP-9 and TIMP-2 and reduced TIMP- 1 in carcinomas suggest a favorable condition for tumor evolution.

1 January 2019 in Ciência Animal Brasileira
Verified
Journal Article
Open access
PDF file
DTDenise Caroline Toledo
Denise Caroline Toledo
MFMariana Batista Rodrigues Faleiro
Mariana Batista Rodrigues Faleiro
HFHugo Henrique Ferreira
Hugo Henrique Ferreira
AFAdriana Marques Faria
Adriana Marques Faria
MMMoema Pacheco Chediak Matos
Moema Pacheco Chediak Matos
Veridiana Maria Brianezi Dignani de MouraVeridiana Maria Brianezi Dignani de Moura
Veridiana Maria Brianezi Dignani de Moura
Resumo O fator de crescimento transformador-β (TGF-β), um mediador do crescimento prostático, induz a angiogênese e inibe a proliferação celular. Neste estudo, esse marcador foi utilizado com o objetivo de avaliar sua imunomarcação no tecido normal e com lesões proliferativas benignas, pré-neoplásicas e neoplásicas da próstata canina. Para isso, foram selecionadas 54 glândulas com histomorfologia normal, hiperplasia prostática benigna (HPB) epitelial, HPB estromal, atrofia inflamatória proliferativa (PIA), neoplasia intraepitelial prostática (PIN) e carcinoma, utilizadas para a confecção de um bloco de microarranjo tecidual (Tissue Microarray - TMA). As lâminas de TMA foram submetidas à técnica de imunoistoquímica com o anticorpo anti-TGF-β, sendo avaliada a intensidade de imunomarcação nas células epiteliais e estromais. Houve imunomarcação de TGF-β no tecido normal e naqueles com lesões proliferativas. Maior imunomarcação de TGF-β foi constatada nas células do tecido prostático normal e com HPB, enquanto as células prostáticas com PIA, PIN e carcinoma exibiram menor imunomarcação dessa citocina, o que sugere a ação do TGF-β na manutenção da homeostase do tecido normal e com lesão proliferativa benigna e na progressão das lesões proliferativas pré-malignas e malignas da próstata canina.